Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: A PET study with [11C]NNC112

Psychopharmacology

Volumn 231, Issue 21, 2014, Pages 4231-4240

  Thompson, Judy L ^a,d   Rosell, Daniel R ^b,c   Slifstein, Mark ^a   Girgis, Ragy R ^a   Xu, Xiaoyan ^a   Ehrlich, Yosefa ^b,c   Kegeles, Lawrence S ^a   Hazlett, Erin A ^b,c   Abi Dargham, Anissa ^a   Siever, Larry J ^b,c  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Dopamine; PET; Prefrontal cortex; Schizophrenia; Schizotypal personality disorder; Working memory

Indexed keywords

5 (7 BENZOFURANYL) 8 CHLORO 2,3,4,5 TETRAHYDRO 7 HYDROXY 3 METHYL 1H 3 BENZAZEPINE; CARBON 11; DOPAMINE 1 RECEPTOR; DOPAMINE;

2 BACK PERFORMANCE TEST; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINERGIC ACTIVITY; FEMALE; HUMAN; IMAGE ANALYSIS; LEARNING AND MEMORY TEST; MALE; MEDIAL PREFRONTAL CORTEX; MEMORY DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PACED AUDITORY SERIAL ADDITION TEST; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; RECEPTOR BINDING; SCHIZOTYPAL PERSONALITY DISORDER; STRIATE CORTEX; TASK PERFORMANCE; WORKING MEMORY; CORPUS STRIATUM; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGY; SCINTISCANNING; SHORT TERM MEMORY;

ADULT; CORPUS STRIATUM; DOPAMINE; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D1; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 84905586265     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3566-6     Document Type: Article

References (39)

1. Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M, Anjilvel S, Pidcock J, Guo NN, Lombardo I, Mann JJ, Van Heertum R, Foged C, Halldin C, Laruelle M (2000) Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab 20:225-243
2. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M (2002) Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22:3708-3719
3. Abi-Dargham A, Kegeles LS, Zea-Ponce Y, Mawlawi O, Martinez D, Mitropoulou V, O'Flynn K, Koenigsberg HW, Van Heertum R, Cooper T, Laruelle M, Siever LJ (2004) Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry 55:1001-1006
4. Abi-Dargham A, Xu X, Thompson JL, Gil R, Kegeles LS, Urban N, Narendran R, Hwang DR, Laruelle M, Slifstein M (2012) Increased prefrontal cortical D(1) receptors in drug naive patients with schizophrenia: a PET study with [(11)C]NNC112. J Psychopharmacol 26:794-805
5. APA (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC
6. Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS (1994) Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) 116:143-151
7. Barch DM, Mitropoulou V, Harvey PD, New AS, Silverman JM, Siever LJ (2004) Context-processing deficits in schizotypal personality disorder. J Abnorm Psychol 113:556-568
8. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B 57:289-300
9. Cohen JD, Perlstein WM, Braver TS, Nystrom LE, Noll DC, Jonides J, Smith EE (1997) Temporal dynamics of brain activation during a working memory task. Nature 386:604-608
10. Ekelund J, Slifstein M, Narendran R, Guillin O, Belani H, Guo NN, Hwang Y, Hwang DR, Abi-Dargham A, Laruelle M (2007) In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390. Mol Imaging Biol 9:117-125
11. First MB, Spitzer RL, Gibbon M, Williams JBW (1994) Structured Clinical Interview for DSM-IV Axis-I Disorders, Version 2.0. Biometrics Research New York State Psychiatric Institute, New York
12. Fischer H, Nyberg L, Karlsson S, Karlsson P, Brehmer Y, Rieckmann A, MacDonald SW, Farde L, Backman L (2010) Simulating neurocognitive aging: effects of a dopaminergic antagonist on brain activity during working memory. Biol Psychiatry 67:575-580
13. Green MF (2006) Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 67(Suppl 9):3-8
14. Gronwall DM (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44:367-373
15. Guo N, Hwang DR, Lo ES, Huang YY, Laruelle M, Abi-Dargham A (2003) Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia. Neuropsychopharmacology 28:1703-1711
16. Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L (1994) Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11:245-256
17. Hurlemann R, Matusch A, Kuhn KU, Berning J, Elmenhorst D, Winz O, Kolsch H, Zilles K, Wagner M, Maier W, Bauer A (2008) 5-HT2A receptor density is decreased in the at-risk mental state. Psychopharmacology (Berl) 195:579-590
18. Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T, Harkavy-Friedman JM, Gil R, Laruelle M, Abi-Dargham A (2010) Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18 F]fallypride positron emission tomography. Biol Psychiatry 68:634-641
19. Kosaka J, Takahashi H, Ito H, Takano A, Fujimura Y, Matsumoto R, Nozaki S, Yasuno F, Okubo Y, Kishimoto T, Suhara T (2010) Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia. Life Sci 86:814-818
20. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D2 receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21:1034-1057
21. McClure MM, Barch DM, Flory JD, Harvey PD, Siever LJ (2008) Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum. J Abnorm Psychol 117:342-354
22. McClure MM, Harvey PD, Goodman M, Triebwasser J, New A, Koenigsberg HW, Sprung LJ, Flory JD, Siever LJ (2010) Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. Neuropsychopharmacology 35:1356-1362
23. Minzenberg MJ, Xu K, Mitropoulou V, Harvey PD, Finch T, Flory JD, New AS, Goldman D, Siever LJ (2006) Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups. Psychiatr Genet 16:117-124
24. Mitropoulou V, Harvey PD, Maldari LA, Moriarty PJ, New AS, Silverman JM, Siever LJ (2002) Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol Psychiatry 52:1175-1182
25. Mitropoulou V, Harvey PD, Zegarelli G, New AS, Silverman JM, Siever LJ (2005) Neuropsychological performance in schizotypal personality disorder: importance of working memory. Am J Psychiatry 162:1896-1903
26. Narendran R, Frankle WG, Keefe R, Gil R, Martinez D, Slifstein M, Kegeles LS, Talbot PS, Huang Y, Hwang DR, Khenissi L, Cooper TB, Laruelle M, Abi-Dargham A (2005) Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry 162:2352-2359
27. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR (2008) The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry 165:203-213
28. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T (1994) Diagnostic Interview for Genetic Studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859
29. Pfohl B, Blum N, Zimmerman M (1997) Structured Interview for DSM-IV Personality: SIDP-IV. American Psychiatric Publishing, Washington, DC
30. Poels EM, Girgis RR, Thompson JL, Slifstein M, Abi-Dargham A (2013) In vivo binding of the dopamine-1 receptor PET tracers [(11)C]NNC112 and [(11)C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacology (Berl) 228:167-174
31. Rasmussen H, Erritzoe D, Andersen R, Ebdrup BH, Aggernaes B, Oranje B, Kalbitzer J, Madsen J, Pinborg LH, Baare W, Svarer C, Lublin H, Knudsen GM, Glenthoj B (2010) Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia. Arch Gen Psychiatry 67:9-16
32. Rosell DR, Zaluda LC, McClure MM, Strike KS, Barch DM, Harvey PD, Girgis RR, Lieberman JA, Siever LJ (2013) Clinical testing of a D1 agonist for cognitive enhancement in the schizophrenia spectrum Society of Biological Psychiatry 68th Annual Scientific Meeting. CA, USA, San Francisco
33. Sawaguchi T, Goldman-Rakic PS (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251:947-950
34. Siever LJ, Davis KL (2004) The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am J Psychiatry 161:398-413
35. Sjogren P, Thomsen AB, Olsen AK (2000) Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manag 19:100-108
36. Slifstein M, Kegeles LS, Gonzales R, Frankle WG, Xu X, Laruelle M, Abi-Dargham A (2007) [11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects. J Cereb Blood Flow Metab 27:1733-1741
37. Slifstein M, Kolachana B, Simpson EH, Tabares P, Cheng B, Duvall M, Gordon Frankle W, Weinberger DR, Laruelle M, Abi-Dargham A (2008) COMT genotype predicts cortical-limbic D1 receptor availability measured with [(11)C]NNC112 and PET. Mol Psychiatry 13:821-827
38. Tombaugh TN (2006) A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Arch Clin Neuropsychol 21:53-76
39. Tsukada H, Nishiyama S, Fukumoto D, Sato K, Kakiuchi T, Domino EF (2005) Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys. Neuropsychopharmacology 30:1861-1869